Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2003
Comparison of HGF (hepatocyte growth factor) levels of epithelial ovarian cancer cyst fluids with benign ovarian cystsC Baykal, E Demirtas, A Al, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2004
Comparison of hepatocyte growth factor levels of epithelial ovarian cancer cyst fluids with benign ovarian cystsC Baykal, E Demirtaş, A Al, et al.
European Journal of Gynaecological Oncology|October 21, 2004
Primary fallopian tube carcinoma: a retrospective multicenter studyG Tulunay, M Arvas, B Demir, et al.
Cancer Letters|April 22, 1999
Treatment results and prognostic factors in inoperable carcinoma of the cervix treated with external plus high dose brachytherapyM Garipagaoglu, S Yalvac, M F Kose, et al.
Gynecologic Oncology|January 22, 2005
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinomaM F Kose, J Sufliarsky, S Beslija, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
Immunohistochemical expression of CD10 antigen in uterine adenosarcomaF Amant, E Steenkiste, K Schurmans, et al.
Gynecologic Oncology|July 20, 2010
Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patientsD Aktas, M Gultekin, S Kabacam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 16, 2007
Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factorsI L Atahan, F Yildiz, E Ozyar, et al.
British Journal of Cancer|July 14, 2011
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancerC K Lee, H Gurney, C Brown, et al.
Pageof 3